Immunome, Inc.
IL-38-SPECIFIC ANTIBODIES
Last updated:
Abstract:
This invention relates to antibodies specific for human interleukin-38 (IL-38), including isolated antibodies, or antigen-binding fragments thereof. The antibodies, or antigen-binding fragments thereof, described here partially or fully block, inhibit, or neutralize a biological activity of IL 38. Methods described here relate to inhibiting tumor growth or metastasis in an individual afflicted by tumor growth and/or metastasis.
Status:
Application
Type:
Utility
Filling date:
30 Jul 2020
Issue date:
1 Sep 2022